Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Tennessee Medical Policy Updates – February 2024
Click here to view the Blue Cross Blue Shield BCBS Tennessee Medical Policy Updates »
February 2024 BCBS Tennessee Medical Policy Updates:
- ADAMTS13, recombinant-krhn (Adzynma)
- Chronic Intermittent Intravenous Insulin Therapy
- Cipaglucosidase Alfa-atga (Pombiliti™)
- Toripalimab-tpzi (Loqtorzi)
- Artificial Intervertebral Disc
- Bioengineered Skin and Soft Tissue Substitutes
- Continuous Home Pulse Oximetry
- Intensity-Modulated Radiotherapy (IMRT) of the Breast and Lung
- Pancreas/Pancreas-Kidney/Pancreatic Islet Cell Transplantation
- Pneumatic Compression Pumps
- Bevacizumab for the Treatment of Neoplastic Disease
- Aflibercept
- DaxibotulinumtoxinA-lanm (Daxxify™)
- Infliximab
- Lanreotide
- Motixafortide (Aphexda™)
- Pozelimab-bbfg (Veopoz®)
- Pegfilgrastim
- Rituximab and Hyaluronidase Human Injection
- Ranibizumab
- Rituximab Products (Rituxan®, Rituximab-abbs [Truxima®],Rituximab-arrx [Riabni™] and Rituximab-pvvr [Ruxience®]) (Oncology Indications)
- Trastuzumab
- Trastuzumab and Hyaluronidase-oysk
- Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body Composition
- Urinary Metabolite Tests for Adherence to Direct-Acting Antiviral Medications for Hepatitis C
- Transcatheter Hepatic Arterial Chemoembolization
- Stem Cell Therapy for Peripheral Artery Disease
- Saturation Biopsy for Diagnosis and Staging of Prostate Cancer
- Spinal Unloading Devices for the Treatment of Low Back Pain
- Retinal Telescreening for Diabetic Retinopathy
- Prolotherapy for Musculoskeletal Disorders
- Positron Emission Tomography (PET) for Cardiac Applications
- Piezoelectric Sensor Analysis and Oscillating Force Delivered Vertebral Adjustment in the Evaluation and Treatment of the Spinal Column
- Pharmacogenetic Testing for Pain Management
- Palatal Implants for the Treatment of Obstructive Sleep Apnea or Snoring
- Ophthalmologic Techniques for the Evaluation of Glaucoma
- Orthoptic Training for the Treatment of Vision or Learning Disabilities
- Nonoperative Diagnostic Spinal Ultrasound (Echography/Sonogram)
- Microprocessor-Controlled Prostheses for the Lower Limb
- Liposuction
- Intradiscal Annuloplasty and Intraosseous Radiofrequency Ablation for Treatment of Back Pain
- Home Nutritional Support (Total Parenteral / Enteral Nutrition)
- Functional Neuromuscular Electrical Stimulation
- Endovascular Therapies for Extracranial Vertebral Artery Disease
- Bulking Agents for the Treatment of Vesicoureteral Reflux (VUR) and Incontinence
- Verteporfin
- Velaglucerase Alfa
- Rituximab Products (Rituxan®, Rituximab-abbs [Truxima®],Rituximab-arrx [Riabni™] and Rituximab-pvvr [Ruxience®]) (Non-Oncology Indications)
- Pembrolizumab
- Pasireotide (Signifor® LAR)
- Imiglucerase
- Hyaluronan Derivatives for Intra-Articular Injection
- Faricimab-svoa (Vabysmo™)
- Eflapegrastim-xnst (Rolvedon™)
- Eculizumab
- Brolucizumab-dbll
Click here to view the Blue Cross Blue Shield BCBS Tennessee Medical Policy Updates »
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
